Viewing Study NCT03533751


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2025-12-25 @ 9:34 PM
Study NCT ID: NCT03533751
Status: COMPLETED
Last Update Posted: 2023-05-24
First Post: 2018-04-27
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Sponsor: AnaptysBio, Inc.
Organization: